Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Amphastar Pharmaceuticals (AMPH) Deferred Taxes (2019 - 2021)

Amphastar Pharmaceuticals has reported Deferred Taxes over the past 5 years, most recently at $2.8 million for Q4 2021.

For Q4 2021, Deferred Taxes fell 26.79% year-over-year to $2.8 million; the TTM value through Dec 2021 reached $4.6 million, up 2728.4%, while the annual FY2025 figure was -$28.7 million, 260.36% down from the prior year.
Deferred Taxes for Q4 2021 was $2.8 million at Amphastar Pharmaceuticals, down from $3.8 million in the prior quarter.
Over five years, Deferred Taxes peaked at $5.3 million in Q4 2019 and troughed at -$2.0 million in Q3 2020.
A 3-year average of $1.7 million and a median of $2.8 million in 2021 define the central range for Deferred Taxes.
Biggest five-year swings in Deferred Taxes: decreased 28.71% in 2020 and later decreased 26.79% in 2021.
Year by year, Deferred Taxes stood at $5.3 million in 2019, then decreased by 28.71% to $3.8 million in 2020, then dropped by 26.79% to $2.8 million in 2021.
Business Quant data shows Deferred Taxes for AMPH at $2.8 million in Q4 2021, $3.8 million in Q4 2020, and -$2.0 million in Q3 2020.